Data / Medical devices / Israel / Brainsway Ltd.
Brainsway Ltd.: FDA-registered device maker in Jerusalem, Israel, 9 510(k) clearances
Brainsway Ltd. is registered with the FDA (registration 3010300912) in Jerusalem, Israel. It lists 3 device types. The FDA files 9 510(k) clearances under its listings, the newest dated August 26, 2022. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3010300912
- Address
- 16 Hartom Str. Har Hahotzvim, Jerusalem, Israel, 9777516
- Owner or operator
- Brainsway Ltd. (10044527)
- Roles
- Manufacturer
- First device listed
- June 24, 2013
- Registered through
- 2026
- Brand names listed
- BrainsWay Deep TMS System for Smoking Cessation (Model 102), BrainsWay Deep TMS System for Smoking Cessation (Model 104), BrainsWay Deep TMS System for Treatment of Decreasing Anxiety Symptoms in MDD (Model 102 & 104), BrainsWay Deep TMS System for Treatment of Major Depressive Disorder (MDD) (Model 102), BrainsWay Deep TMS System for Treatment of Major Depressive Disorder (MDD) (Model 104), BrainsWay Deep TMS System for Treatment of Major Depressive Disorder (MDD) using iTBS (Model 102 & 104), BrainsWay Deep TMS System for Treatment of Obsessive Compulsive Disorder (OCD) (Model 102), BrainsWay Deep TMS System for Treatment of Obsessive Compulsive Disorder (OCD) (Model 104) and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder | QCI | 2 | Manufacturer | accessdata.fda.gov |
| Transcranial Magnetic Stimulation System For Smoking Cessation | QMD | 2 | Manufacturer | accessdata.fda.gov |
| Transcranial Magnetic Stimulator | OBP | 2 | Manufacturer | accessdata.fda.gov |
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| August 26, 2022 | K220819 | BrainsWay Deep TMS System | OBP | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| August 17, 2021 | K210201 | Deep Transcranial Magnetic Stimulation (DTMS) System | OBP | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| April 23, 2021 | K203735 | Brainsway Deep TMS System | OBP | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| April 16, 2021 | K203616 | Brainsway Deep (DTMS) System | QMD | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| August 21, 2020 | K200957 | Brainsway Deep TMS System | QMD | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| March 8, 2019 | K183303 | Brainsway Deep TMS System | QCI | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| August 17, 2018 | DEN170078 | Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System | QCI | Unknown | Brainways , Ltd. | accessdata.fda.gov |
| May 3, 2018 | K173540 | Brainsway Deep (DTMS) System | OBP | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
| January 7, 2013 | K122288 | BRAINSWAY DEEP TMS SYSTEM | OBP | Substantially Equivalent | Brainsway , Ltd. | accessdata.fda.gov |
Compare with other makers
- All makers of Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder
- All makers of Transcranial Magnetic Stimulator
Updated August 26, 2022. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.